Screening for Anxiety Disorders in Adults

Iris Mabry-Hernandez, MD, MPH,
Medical Officer, U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality
Susan J. Ching, DO,
Preventive Medicine Resident, Uniformed Services University of the Health Sciences

American Family Physician. 2024;109(5):457-458.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Case Study

A 34-year-old patient (gravida 2, para 2) presents for a well-woman examination and Papanicolaou smear. She feels healthy and has no significant medical history, aside from her uncomplicated pregnancies, which did not include postpartum depression or anxiety. She reports increased stress at home due to an upcoming move and some difficulty sleeping.

Case Study Questions

1. According to the U.S. Preventive Services Task Force (USPSTF) recommendation, which one of the following is advised for this patient?

  • A. Screen for anxiety disorder.
  • B. Assess her anxiety in 6 months.
  • C. Refer her to an obstetrician-gynecologist for postpartum anxiety screening.
  • D. Recommend melatonin.
  • E. Refer her to a behavioral health professional for sleep management.

2. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5), which of the following can be categorized as anxiety disorders?

  • A. Generalized anxiety disorder.
  • B. Obsessive-compulsive disorder.
  • C. Separation anxiety disorder.
  • D. Social anxiety disorder.

3. Which one of the following populations should be screened for anxiety disorders, according to the USPSTF recommendation?

  • A. People already diagnosed with anxiety or another mental health disorder.
  • B. People younger than 18 years.
  • C. People older than 65 years.
  • D. People with no recognized signs or symptoms of anxiety disorders.

Answers

  1. The correct answer is A. The USPSTF recommends screening all adults 19 to 64 years of age for anxiety disorder, including those who are pregnant and postpartum. The USPSTF notes there is little evidence for the ideal timing and frequency of anxiety screening for perinatal and general adult populations.1 However, clinical judgment, particularly considering risk factors, comorbid conditions, and life events, can determine whether additional screening of high-risk patients is warranted. There is a lack of evidence on screening rates for anxiety disorders. Underdetection appears to be common. Patients with anxiety disorders may present with other concerns, such as sleep disturbances or somatic issues.
  2. The correct answers are A, C, and D. The DSM-5 recognizes the following types of anxiety disorders: generalized anxiety disorder, social anxiety disorder, panic disorder, agoraphobia, specific phobias, separation anxiety disorder, selective mutism, substance or medication-induced anxiety disorder, anxiety disorder due to another medical condition, and anxiety not otherwise specified.2 Obsessive-compulsive disorder is not considered an anxiety disorder.
  3. The correct answer is D. The USPSTF recommendation statement applies to adults (defined as those 19 to 64 years of age), including people who are pregnant or postpartum, who do not have a diagnosed mental health disorder and are not showing recognized signs or symptoms of anxiety disorders.2 For people 65 years or older, the USPSTF concludes that the evidence is insufficient to recommend for or against screening for anxiety disorders.

The views expressed in this work are those of the authors and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences, the U.S. Department of Defense, or the U.S. government.

This PPIP quiz is based on the recommendations of the USPSTF. More information is available in the USPSTF Recommendation Statement and supporting documents on the USPSTF website (https://www.uspreventiveservicestaskforce.org). The practice recommendations in this activity are available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening.

Author disclosure: No relevant financial relationships.

  1. 1.O’Connor EA, Henninger ML, Perdue LA, et al. Anxiety screening: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;329(24):2171-2184.
  2. 2.Barry MJ, Nicholson WK, Silverstein M, et al. Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(24):2163-2170.

This series is coordinated by Joanna Drowos, DO, contributing editor.

A collection of Putting Prevention Into Practice published in AFP is available at https://www.aafp.org/afp/ppip.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.